HIGHFDA DEVICE

Agilent Technologies Denmark ApS Recalls 67 FLEX CD20 Antibody for Potential Weak Staining

Agilent Technologies Denmark ApS recalled 67 FLEX Monoclonal Mouse Anti-Human CD20cy, Clone L26, Ready-to-Use antibodies sold nationwide in the United States. The antibody may stain weakly, potentially producing false negative CD20 results. Healthcare facilities should stop using the device immediately and follow manufacturer recall instructions.

Official notice

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DEVICE
Recall date
August 11, 2025
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
August 11, 2025
Hazard Level
HIGH
Brand
Agilent Technologies Denmark ApS
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Medical Devices; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
Agilent Technologies Denmark ApS
Product type
Immunohistochemistry Antibody
Model numbers
GA60461-2J
Sold at
Multiple Retailers
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    August 11, 2025

  2. Reported by FDA DEVICE

    September 24, 2025

  3. RecallRadar source check

    April 18, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Their is the potential for weak staining which may result in false negative CD20 identification.

What You Should Do

Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Agilent Technologies Denmark ApS or your healthcare provider for instructions. Notification method: N/A

About This Product

This immunohistochemistry reagent is used to label CD20 on B cells in tissue samples. The L26 clone is a monoclonal antibody designed for use with Dako Omnis instruments to aid in classifying B-cell neoplasms.

Why This Is Dangerous

If staining is weak, CD20 may appear absent on slides. This can lead to misclassification and potential misdiagnosis in pathology workflows.

Industry Context

This recall is not part of a broader industry pattern.

Real-World Impact

Labs may need to halt testing with the affected lot, implement alternative antibodies, and coordinate with leadership to prevent diagnostic delays while awaiting replacement.

Practical Guidance

How to identify if yours is affected

  1. Verify model GA60461-2J on the product packaging and vial label.
  2. Check lot number 41810156 on the vial and accompanying documentation.
  3. Confirm product was distributed in the United States and is within the recall scope.

Where to find product info

Identify serial numbers, lot numbers, and GTIN on the vial label and packaging. Manufacturer recall notices provide the official identifiers.

What timeline to expect

4-8 weeks for remedy processing and replacement or guidance, varies by facility and supplier.

If the manufacturer is unresponsive

  • Escalate to institutional procurement or compliance departments.
  • Document all attempts to contact the manufacturer and maintain a log.

How to prevent similar issues

  • Implement recall monitoring for reagents and antibodies.
  • Verify supplier recall status before using antibodies in diagnostic workflows.
  • Adopt validated alternative antibodies and keep a list of approved substitutes.

Documentation advice

Keep the recall notice, product labels, lot numbers, purchase records, and all communications with the manufacturer as part of the incident file.

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

Model/ Catalog Number: GA60461-2J; Lot numbers: 41810156; GTIN: 41741883. Distribution: US nationwide in states including Alabama, California, Colorado, Connecticut, Florida, Georgia, Illinois, Indiana, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Mississippi, Nevada, New Jersey, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas, Virginia, Washington, West Virginia, Wisconsin. Sold at: Unknown. Sold since: Unknown. Price: Unknown.

Reported Incidents

No injuries or incidents have been reported.

Key Facts

  • Model GA60461-2J; Lot 41810156
  • US nationwide distribution listed by state
  • High-hazard recall due to potential diagnostic inaccuracy

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Classification

Product TypeImmunohistochemistry Antibody
Sold At
Multiple Retailers

Product Details

Model Numbers
GA60461-2J
Affected States
ALL
Report Date
September 24, 2025
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
MEDIUM

Taro Pharmaceuticals Withdraws Diclofenac Sodium Gel Over Viscosity Issues

Taro Pharmaceuticals announced a market withdrawal of Diclofenac Sodium, Topical Gel, 3% on January 27, 2026. The withdrawal stems from out of specification viscosity results. Healthcare providers and consumers should stop using the product immediately.

BEEKEEPER'S NATURALS USA
Microbial Contamination
Read more
Health & Personal Care
MEDIUM

AvKARE Recalls Rosuvastatin Tablets Due to Dissolution Issues

AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.

SUN PHARMACEUTICAL INDUSTRIES
Labeling: Not
Read more